Compare · ALC vs LUCY
ALC vs LUCY
Side-by-side comparison of Alcon Inc. (ALC) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $36.66B, about 3980.0x LUCY ($9.2M).
- LUCY has been more active in the news (12 items in the past 4 weeks vs 3 for ALC).
- ALC has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Alcon Inc.
- Innovative Eyewear Inc.
- Price
- -
- -
- Market cap
- $36.66B
- $9.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2022
- News (4w)
- 3
- 12
- Recent ratings
- 25
- 0
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Latest ALC
- Alcon downgraded by BNP Paribas Exane with a new price target
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- SEC Form SD filed by Alcon Inc.
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
- Alcon Announces Results of 2026 Annual General Meeting
- Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
- Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
Latest LUCY
- Chief Financial Officer Gayle Oswald was granted 32,466 shares and sold $13,491 worth of shares (15,533 units at $0.87), increasing direct ownership by 591% to 19,798 units (SEC Form 4)
- Chief AI & Growth Officer Dabrowski Konrad sold $11,874 worth of shares (13,627 units at $0.87) and was granted 41,800 shares, increasing direct ownership by 220% to 40,977 units (SEC Form 4)
- Chief Operating Officer Abondano Joaquin was granted 29,600 shares and sold $8,414 worth of shares (9,799 units at $0.86), increasing direct ownership by 380% to 25,012 units (SEC Form 4)
- Chief Executive Officer Gross Harrison R. was granted 49,200 shares and sold $24,411 worth of shares (27,738 units at $0.88), increasing direct ownership by 156% to 35,195 units (SEC Form 4)
- Chief Technology Officer Cohen David Eric was granted 36,400 shares and sold $14,587 worth of shares (15,769 units at $0.93), increasing direct ownership by 307% to 27,342 units (SEC Form 4)
- Innovative Eyewear, Inc. Announces Strategic Alliance with HTC Corporation
- Innovative Eyewear Announces Expansion Into More than 150 Stores of One of the Largest Big Box Retailers in the United States
- Innovative Eyewear, Inc. Announces Major New AI and News Features for Lucyd App
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear Inc. Reports Record Second Quarter 2026 Results